SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-073603
Filing Date
2023-09-05
Accepted
2023-09-05 08:56:24
Documents
14
Period of Report
2023-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea184657-8k_avalon.htm   iXBRL 8-K 27567
2 PRESS RELEASE ISSUED BY AVALON GLOBOCARE CORP., DATED SEPTEMBER 5, 2023 ea184657ex99-1_avalon.htm EX-99.1 9153
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3034
  Complete submission text file 0001213900-23-073603.txt   218964

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE albt-20230905.xsd EX-101.SCH 3039
5 XBRL LABEL FILE albt-20230905_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE albt-20230905_pre.xml EX-101.PRE 22375
8 EXTRACTED XBRL INSTANCE DOCUMENT ea184657-8k_avalon_htm.xml XML 3316
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 231234255
SIC: 2836 Biological Products, (No Diagnostic Substances)